% Created 2019-01-30 Wed 16:06
% Intended LaTeX compiler: pdflatex
\documentclass[11pt]{article}
\usepackage[utf8]{inputenc}
\usepackage[T1]{fontenc}
\usepackage{graphicx}
\usepackage{grffile}
\usepackage{longtable}
\usepackage{wrapfig}
\usepackage{rotating}
\usepackage[normalem]{ulem}
\usepackage{amsmath}
\usepackage{textcomp}
\usepackage{amssymb}
\usepackage{capt-of}
\usepackage{hyperref}
\usepackage{tikz}
\usepackage{float}
\def\checkmark{\tikz\fill[scale=0.4](0,.35) -- (.25,0) -- (1,.7) -- (.25,.15) -- cycle;}
\author{Patt}
\date{\today}
\title{}
\hypersetup{
 pdfauthor={Patt},
 pdftitle={},
 pdfkeywords={},
 pdfsubject={},
 pdfcreator={Emacs 25.3.1 (Org mode 9.2)}, 
 pdflang={English}}
\begin{document}

\begin{center}
\begin{tabular}{llrr}
Normal Media & Statin treated & Up in MDM2 High & Up in MDM2 Low\\
\hline
\(\checkmark\) & x & 13 & 46\\
\(\checkmark\) & \(\checkmark\) & 13 & 60\\
x & x & 13 & 29\\
\(\checkmark\) & \(\checkmark\) & 0 & 5\\
\end{tabular}
\end{center}


\begin{center}
\begin{tabular}{lrr}
Ceramide & Glyc/NonGlyc in MDM2 High & Glyc/NonGlyc in MDM2 Low\\
\hline
Cer(d18:1/16:0) & 1.013978 & 0.9467653\\
Cer(d18:1/24:1) & 1.018272 & 0.9472406\\
Cer(d18:1/25:0) & 1.029759 & 1.001818\\
\end{tabular}
\end{center}

Pathway Results

\begin{center}
\begin{tabular}{lrlr}
Pathway & Fisher's p val & Lipid & Log2(MDM2 High/MDM2 Low)\\
\hline
Membrane Trafficking & 0.018 & PC(15:1$\backslash$\textsubscript{22}:6) & -1.73562017918373\\
 &  & PC(16:0$\backslash$\textsubscript{22}:6) & -1.53201004103487\\
 &  & PC(16:1$\backslash$\textsubscript{16}:1) & -1.6208020481119\\
 &  & PC(16:1$\backslash$\textsubscript{17}:1) & -2.87204252360003\\
 &  & PC(17:1$\backslash$\textsubscript{18}:1) & -1.35721056541973\\
 &  & PC(18:1$\backslash$\textsubscript{22}:6) & -2.07182333690837\\
 &  & PC(20:1$\backslash$\textsubscript{24}:1) & -1.36169016276703\\
 &  & PC(18:1$\backslash$\textsubscript{25}:0) & -1.10908107812709\\
\hline
Innate Immune System & 0.029 & PC(15:1$\backslash$\textsubscript{22}:6) & -1.73562017918373\\
 &  & PC(16:0$\backslash$\textsubscript{22}:6) & -1.53201004103487\\
 &  & PC(16:1$\backslash$\textsubscript{16}:1) & -1.6208020481119\\
 &  & PC(16:1$\backslash$\textsubscript{17}:1) & -2.87204252360003\\
 &  & PC(17:1$\backslash$\textsubscript{18}:1) & -1.35721056541973\\
 &  & PC(18:1$\backslash$\textsubscript{22}:6) & -2.07182333690837\\
 &  & PC(20:1$\backslash$\textsubscript{24}:1) & -1.36169016276703\\
 &  & PC(18:1$\backslash$\textsubscript{25}:0) & -1.10908107812709\\
 &  & DG(20:4$\backslash$\textsubscript{20}:4) & 1.83017684393296\\
\hline
Plasma lipoprotein assembly, & 0.041 & PC(15:1$\backslash$\textsubscript{22}:6) & -1.73562017918373\\
remodeling, and clearance &  & PC(16:0$\backslash$\textsubscript{22}:6) & -1.53201004103487\\
 &  & PC(16:1$\backslash$\textsubscript{16}:1) & -1.6208020481119\\
 &  & PC(16:1$\backslash$\textsubscript{17}:1) & -2.87204252360003\\
 &  & PC(17:1$\backslash$\textsubscript{18}:1) & -1.35721056541973\\
 &  & PC(18:1$\backslash$\textsubscript{22}:6) & -2.07182333690837\\
 &  & PC(20:1$\backslash$\textsubscript{24}:1) & -1.36169016276703\\
 &  & PC(18:1$\backslash$\textsubscript{25}:0) & -1.10908107812709\\
 &  & DG(20:4$\backslash$\textsubscript{20}:4) & 1.83017684393296\\
\hline
HDL remodeling & 0.041 & PC(15:1$\backslash$\textsubscript{22}:6) & -1.73562017918373\\
 &  & PC(16:0$\backslash$\textsubscript{22}:6) & -1.53201004103487\\
 &  & PC(16:1$\backslash$\textsubscript{16}:1) & -1.6208020481119\\
 &  & PC(16:1$\backslash$\textsubscript{17}:1) & -2.87204252360003\\
 &  & PC(17:1$\backslash$\textsubscript{18}:1) & -1.35721056541973\\
 &  & PC(18:1$\backslash$\textsubscript{22}:6) & -2.07182333690837\\
 &  & PC(20:1$\backslash$\textsubscript{24}:1) & -1.36169016276703\\
 &  & PC(18:1$\backslash$\textsubscript{25}:0) & -1.10908107812709\\
 &  & DG(20:4$\backslash$\textsubscript{20}:4) & 1.83017684393296\\
\end{tabular}
\end{center}
\end{document}